[Value and limitations of substitution treatments in the care of drug addicts].
Carpentier
J
J
Bloch-Lainé
J F
JF
Hefez
S
S
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D002047:Buprenorphine / Q000627:therapeutic use; D005602:France; D015658:HIV Infections / Q000150:complications; D006679:HIV Seropositivity / Q000150:complications; D006801:Humans; D001523:Mental Disorders / Q000150:complications; D008691:Methadone / Q000627:therapeutic use; D009020:Morphine / Q000627:therapeutic use; D010297:Paris; D019966:Substance-Related Disorders / Q000150:complications / Q000534:rehabilitation*; D013997:Time Factors
D002047:Buprenorphine; D009020:Morphine; D008691:Methadone
Intérêts et limites des traitements de substitution dans la prise en charge des toxicomanes.